Real-World Evidence From More Than 1000 Patients Treated With Adalimumab For Moderate-to-Severe Psoriasis in the Czech Republic

INTRODUCTION: The study aimed to evaluate the real-world effectiveness of adalimumab as well as investigate the persistence of treatment and identify factors, which may affect it. METHODS: More than 1150 patients (4363.1 patient-years) with psoriasis who had been treated with adalimumab since the st...

Descripción completa

Detalles Bibliográficos
Autores principales: Kojanova, Martina, Cetkovska, Petra, Strosova, Daniela, Fialova, Jorga, Arenberger, Petr, Dolezal, Tomas, Gkalpakiotis, Spyridon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018917/
https://www.ncbi.nlm.nih.gov/pubmed/33666877
http://dx.doi.org/10.1007/s13555-021-00499-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018917/
https://www.ncbi.nlm.nih.gov/pubmed/33666877
http://dx.doi.org/10.1007/s13555-021-00499-8

Ejemplares similares